Intraventricular administration of morphine and clonidine.
Leong
M S
MS
Department of Anesthesiology, Stanford University School of Medicine, California, USA. msleong@stanford.edu
Calabrese
J F
JF
Heit
G
G
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications; D001943:Breast Neoplasms / Q000150:complications; D018270:Carcinoma, Ductal, Breast / Q000150:complications; D002294:Carcinoma, Squamous Cell / Q000150:complications; D003000:Clonidine / Q000008:administration & dosage / Q000627:therapeutic use*; D005157:Facial Pain / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000627:therapeutic use*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010610:Pharyngeal Neoplasms / Q000150:complications
D000316:Adrenergic alpha-Agonists; D000701:Analgesics, Opioid; D009020:Morphine; D003000:Clonidine